According to
“As well, the greenhouses are a very small fraction of the planned builds but allow us to test conditions and begin micro-testing genetics. The plan is to run one 90-day cycle and make sure the test parameters yield the expected results.”
Medcana partners will also be running tests in native soil for near-term open-air cultivation possibilities for the Company. For now, the greenhouses give Medcana and partners a controlled environment to ensure native soil results are accurate.
“In order to build something right and well, we must go slow, analyze, and test all variables. We have done a phenomenal job with the initial analysis for infrastructure, with geological, hydrological, and environmental factors. Now we want to test further. All things matter, wind currents, small changes in humidity, soil, pests, we want to make sure all is analyzed and tested,” adds Diaz.
MedCana aims to build its Partner companies into one of the most advanced Cannabinoid production and processing organizations globally
SAFE HARBOR STATEMENT
This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made.
Signed.
/s/
www.medcana.net
info@medcana.co
FOR MORE INFORMATION
PLEASE CONTACT:
512-587-5175
chris@chrisgreta.com
www.medcana.net
info@medcana.co
Attachments
- MedCana's initial focus is on partnering and developing companies in
Latin America with an initial focus inColombia and partnerships with laboratories, research facilities, and hospitals throughout the world. -
Medcana - Nature's
Bio Lab - Medcana, a global infrastructure and holding company in the cannabis industry
MedCana's initial focus is on partnering and developing companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world.
MedCana aims to build our Partner companies into one of the most advanced CBD production and processing organization globally
Medcana - Nature's Bio Lab
Pharmaceutical Grade Cannabidiol
Medcana, a global infrastructure and holding company in the cannabis industry
Medcana’s goal is to be the world's premier resource for pharmaceutical cannabis products
2022 GlobeNewswire, Inc., source